JPRN-jRCT2080220721未知2 期
Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •Decimal visual acuity: 0.5 or better
- •With abnormal visual field measured by the Goldmann perimetry
排除标准
- •The subject has taken steroids and/or vasodilators within 1 month prior to informed consent.
研究者
相似试验
已完成
不适用
Phase I randomized study of 0.15% UF-021 in patients with geographic atrophy treated after wet age-related macular degeneratioAge-related macular degeneraitonJPRN-UMIN000007881Dept. of Ophthalmology, Kagawa university faculty of medicine50
进行中（未招募）
不适用
study in patients with refractory, metastatic cancer harboring KIT mutation or amplification to investigate the clinical efficacy and safety of imatinib therapyNeoplasmsKCT0003729Samsung Medical Center33
招募中
不适用
Phase II trial of regorafenib in patients with unresectable hepatocellular carcinoma after progression on first line atezolizumab plus bevacizumabKCT0006340Bundang CHA General Hospital40
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
已完成
2 期
A phase II clinical study of F-1614 in patients with pheochromocytoma (including paraganglioma)PheochromocytomaJPRN-jRCT2080223695PDRadiopharma Inc.13